The prostate is a gland that is found in every man and weighs 18-20 g in young adult men. It is an organ that is located in the section after the bladder and surrounds this part of the urinary tract. One of the problems encountered with the prostate is prostate cancer. Prostate cancer, which has a high treatment success when diagnosed at an early stage, usually does not show any symptoms in the initial stage. For this reason, men with a family history of prostate cancer should have annual prostate checks from the age of 40, and in any case after the age of 50.
Symptoms may differ
The symptoms of prostate cancer, which has an insidious character, differ according to the stage. Prostate cancer usually does not progress very quickly in the early stages and does not show any symptoms. However, some types can spread quickly and be aggressive. Prostate cancer can cause similar complaints with benign prostate enlargement in the early stages. Difficulty urinating, frequent urination at night, intermittent urination, blood in the semen or urine, and bone pain in advanced stages, which are usually symptoms of benign prostate enlargement, can be seen.
Definitive diagnosis is made by biopsy.
Although PSA elevation in the blood and digital rectal examination can provide information about cancer, the definitive diagnosis of prostate cancer is made by prostate biopsy. In the biopsy procedure, a sample is taken from the prostate tissue for pathological examination. In addition to classical prostate biopsy, fusion prostate biopsy technique has been used in the diagnosis of prostate cancer in recent years.
Fusion prostate biopsy targets tumor and risk areas
The classical prostate biopsy application, which is applied to detect tumors in the prostate gland, has begun to leave its place to fusion prostate biopsy in the light of technological developments. Today, the location and borders of the tumor in the prostate gland can be determined by MRI. Multiparametric Prostate MRI is performed first in the presence of high PSA levels in the blood or suspicious findings in the examination. By means of the fusion biopsy device, these MR images and the prostate images obtained by ultrasonography are superimposed in three dimensions. In this way, needle biopsies are taken from the target tissue by reaching the tumor foci detected by MR accompanied by ultrasonography. With these biopsies taken from the targeted areas, cancer is detected at a higher rate than the classical biopsy. With fusion prostate biopsy, which is a diagnostic method targeting tumors and areas at risk for cancer, delays in diagnosis are prevented and there is no need for repetitive biopsies. This procedure can be performed both under local anesthesia and in operating room conditions, under general anesthesia, by putting the patient to sleep.